Q3 2023 Holdings
Filed 2023-11-14 | 20 holdings | $831.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $163.6M | 2,341,238 | 19.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $112.7M | 2,451,819 | 13.6% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $94.1M | 5,929,592 | 11.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $62.6M | 2,941,176 | 7.5% |
| Merus N V | COM | N5749R100 | $44.4M | 1,881,345 | 5.3% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $43.0M | 2,474,561 | 5.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $41.2M | 83,747 | 5.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $34.7M | 3,558,975 | 4.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $33.7M | 1,142,473 | 4.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $29.1M | 2,131,369 | 3.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $28.8M | 750,000 | 3.5% |
| Rayzebio Inc | COM | 75525N107 | $27.1M | 1,221,904 | 3.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $26.4M | 1,928,503 | 3.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $21.0M | 1,369,623 | 2.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $19.2M | 1,393,329 | 2.3% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $14.2M | 1,901,397 | 1.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $11.3M | 5,163,287 | 1.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $10.3M | 2,040,000 | 1.2% |
| DBV Technologies SA | SPONSORED ADR | 23306J101 | $9.2M | 6,781,150 | 1.1% |
| Aeglea Biotherapeutics Inc(SYRE) | COM NEW | 00773J202 | $4.6M | 378,421 | 0.6% |